Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education

被引:93
作者
Gurwitz, D [1 ]
Lunshof, JE
Dedoussis, G
Flordellis, CS
Fuhr, U
Kirchheiner, J
Licinio, J
Llerena, A
Manolopoulos, V
Sheffield, LJ
Siest, G
Torricelli, F
Vasiliou, V
Wong, S
机构
[1] Tel Aviv Univ, Sackler Fac Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel
[2] VU Univ Med Ctr, Sect Commun Genet, Dept Clin Genet & Human Genet, Amsterdam, Netherlands
[3] Harokopio Univ Athens, Athens, Greece
[4] Univ Patras, Sch Med, Dept Pharmacol, GR-26110 Patras, Greece
[5] Univ Cologne, Dept Pharmacol, Clin Pharmacol Unit, D-5000 Cologne, Germany
[6] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
[7] Univ Extremadura, Sch Med, Dept Pharmacol & Psychiat, E-06071 Badajoz, Spain
[8] Democritus Univ Thrace, Pharmacol Lab, Sch Med, Alexandroupolis, Greece
[9] Univ Melbourne, Genet Hlth Serv Victoria, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[10] Univ Nancy 1, Fac Pharm, INSERM, U 525, Nancy, France
[11] Hosp Univ Careggi, Genet Lab, Florence, Italy
[12] Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA
[13] Med Coll Wisconsin, TDM, Milwaukee, WI 53226 USA
关键词
pharmacogenetics; education; continuing medical education; personalized medicine; adverse drug reactions (ADRs); cytochrome P450 enzymes; thiopurine methyltransferase (TPMT); International Society of Pharmacogenomics (ISP);
D O I
10.1038/sj.tpj.6500312
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
Pharmacogenomics would be instrumental for the realization of personalized medicine in coming decades. Efforts are evident to clarify the potential bioethical, societal, and legal implications of key pharmacogenomics-based technologies projected to be soon introduced into the core practice of medicine. In sharp contrast, a lack of sufficient attention to educational aspects of pharmacogenomics, both for professionals and for society at large, is evident. In order to contribute to this discussion, a 'Pharmacogenomics Education Forum' was held on October 2, 2004 during the 3rd Annual Meeting of the International Society of Pharmacogenomics (ISP) at Santorini, Greece. The participants, members of the ISP Pharmacogenomics Education Forum, after deliberate discussions, proposed a document of 'Background Statement' and 'Recommendations and Call for Action' addressed to Deans of Education at Medical, Pharmaceutical, and Health Schools globally. This document has been considered by the education committee of the International Society of Pharmacogenomics and the result is presented here. We hope that this call would be listened to, and soon followed by beneficial action, ultimately leading to enhanced implementation of personalized medicine into core medical education and practice.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 37 条
[1]
[Anonymous], 2003, PHARM ETH ISS
[2]
AUXTERPARHAM S, 2004, CLIN LAB NEWS, V30, P1
[3]
Pharmacogenetics: ethical problems and solutions [J].
Breckenridge, A ;
Lindpaintner, K ;
Lipton, P ;
McLeod, H ;
Rothstein, M ;
Wallace, H .
NATURE REVIEWS GENETICS, 2004, 5 (09) :676-680
[4]
Continuing-education programs in pharmacogenomics for pharmacists [J].
Brock, TP ;
Faulkner, CM ;
Williams, DM ;
Smith, SR .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (08) :722-725
[5]
The impact of the CYP2D6 polymorphism on haloperidol pharmacoldnetics and on the outcome of haloperidol treatment [J].
Brockmöller, J ;
Kirchheiner, J ;
Schmider, J ;
Walter, S ;
Sachse, C ;
Müller-Oerlinghausen, B ;
Roots, I .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (04) :438-452
[6]
Readmissions and adverse drug reactions in internal medicine:: the economic impact [J].
Dormann, H ;
Neubert, A ;
Criegee-Rieck, M ;
Egger, T ;
Radespiel-Tröger, M ;
Azaz-Livshits, T ;
Levy, M ;
Brune, K ;
Hahn, EG .
JOURNAL OF INTERNAL MEDICINE, 2004, 255 (06) :653-663
[7]
Lack of awareness of community-acquired adverse drug reactions upon hospital admission - Dimensions and consequences of a dilemma [J].
Dormann, H ;
Criegee-Rieck, M ;
Neubert, A ;
Egger, T ;
Geise, A ;
Krebs, S ;
Schneider, TH ;
Levy, M ;
Hahn, EG ;
Brune, K .
DRUG SAFETY, 2003, 26 (05) :353-362
[8]
European Commission, 2004, ETH LEG SOC ASP GEN
[9]
Moving towards individualized medicine with pharmacogenomics [J].
Evans, WE ;
Relling, MV .
NATURE, 2004, 429 (6990) :464-468
[10]
From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community [J].
Frueh, FW ;
Gurwitz, D .
PHARMACOGENOMICS, 2004, 5 (05) :571-579